73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers identify a gene as a potential target in treatment-resistant brain cancer glioblastoma multiforme

Researchers identify a gene as a potential target in treatment-resistant brain cancer glioblastoma multiforme

by University of California, Los AngelesSingle-cell sequencing reveals the diverse functional states of glioma cells post-radiation.aUMAP plot of cell clusters from control (0 Gy) and

Researchers identify a gene as a potential target in treatment-resistant brain cancer glioblastoma multiforme

by University of California, Los AngelesSingle-cell sequencing reveals the diverse functional states of glioma cells post-radiation.aUMAP plot of cell clusters from control (0 Gy) and
Research is uncovering new ways to treat an aggressive brain cancer

Research is uncovering new ways to treat an aggressive brain cancer

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageBrain surgeons need steady hands as well as cool heads. Now they're getting a helping hand from re

Research is uncovering new ways to treat an aggressive brain cancer

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageBrain surgeons need steady hands as well as cool heads. Now they're getting a helping hand from re
Biochemists, cancer biologists find key vulnerability in rare brain tumors

Biochemists, cancer biologists find key vulnerability in rare brain tumors

by Anne Manning,Colorado State UniversityCredit: Pixabay/CC0 Public DomainSince the start of her career, Jennifer DeLuca has been fascinated by mitosis, the everyday biological process of cell d

Biochemists, cancer biologists find key vulnerability in rare brain tumors

by Anne Manning,Colorado State UniversityCredit: Pixabay/CC0 Public DomainSince the start of her career, Jennifer DeLuca has been fascinated by mitosis, the everyday biological process of cell d
Enhanced treatment of liver carcinoma with a drug-eluting hydrogel

Enhanced treatment of liver carcinoma with a drug-eluting hydrogel

by Stewart Han, Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with

Enhanced treatment of liver carcinoma with a drug-eluting hydrogel

by Stewart Han, Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with
Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina
Researchers report encouraging immunotherapy option for relapsed myeloma patients

Researchers report encouraging immunotherapy option for relapsed myeloma patients

by The Mount Sinai HospitalTreatment breakdown of the multiple myeloma patient cohort. (A) Flow chart showing that the initial retrospective query yielded 115 RRMM patients enrolled on a BiAb cli

Researchers report encouraging immunotherapy option for relapsed myeloma patients

by The Mount Sinai HospitalTreatment breakdown of the multiple myeloma patient cohort. (A) Flow chart showing that the initial retrospective query yielded 115 RRMM patients enrolled on a BiAb cli
An intelligent knife can tell ovarian cancer and healthy tissue apart. Could it make surgery smarter?

An intelligent knife can tell ovarian cancer and healthy tissue apart. Could it make surgery smarter?

by Katie Roberts,Cancer Research UKTesting the iKnife in the lab. Credit: Cancer Research UKSurgery is a major part of ovarian cancer treatment, but it can be a blunt tool.A big problem for surg

An intelligent knife can tell ovarian cancer and healthy tissue apart. Could it make surgery smarter?

by Katie Roberts,Cancer Research UKTesting the iKnife in the lab. Credit: Cancer Research UKSurgery is a major part of ovarian cancer treatment, but it can be a blunt tool.A big problem for surg
New precision tools make quick work of tumor dissection

New precision tools make quick work of tumor dissection

by Andrew Myers,Stanford UniversityScanning microscopy images of the microDicer (blade spacings 200 μm, 400 μm, and 800 μm, respectively) and microGrater. Credit: Seth Cordts and Saisneha Koppak

New precision tools make quick work of tumor dissection

by Andrew Myers,Stanford UniversityScanning microscopy images of the microDicer (blade spacings 200 μm, 400 μm, and 800 μm, respectively) and microGrater. Credit: Seth Cordts and Saisneha Koppak
Team establishes positive clinical impact of the Multidisciplinary Molecular Tumor Board

Team establishes positive clinical impact of the Multidisciplinary Molecular Tumor Board

byThe University of Hong KongCredit: Unsplash/CC0 Public DomainA collaborative group led by the Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, the Univers

Team establishes positive clinical impact of the Multidisciplinary Molecular Tumor Board

byThe University of Hong KongCredit: Unsplash/CC0 Public DomainA collaborative group led by the Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, the Univers
Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c
Researchers reveal role of PPDPF in development of mutant KRAS-driven pancreatic ductal adenocarcinoma

Researchers reveal role of PPDPF in development of mutant KRAS-driven pancreatic ductal adenocarcinoma

by Liu Jia,Chinese Academy of SciencesSchematic representation demonstrating the function of PPDPF in KRAS activation. Credit: Dr. XIE Dong's groupA recent study by Dr. Xie Dong's group

Researchers reveal role of PPDPF in development of mutant KRAS-driven pancreatic ductal adenocarcinoma

by Liu Jia,Chinese Academy of SciencesSchematic representation demonstrating the function of PPDPF in KRAS activation. Credit: Dr. XIE Dong's groupA recent study by Dr. Xie Dong's group
Foreign-born women in U.S. less likely to have mammograms

Foreign-born women in U.S. less likely to have mammograms

(HealthDay)—Regardless of the percentage of lifetime spent in the United States, foreign-born women are less likely to ever have received a mammogram compared with U.S.-born women, according to the Oc

Foreign-born women in U.S. less likely to have mammograms

(HealthDay)—Regardless of the percentage of lifetime spent in the United States, foreign-born women are less likely to ever have received a mammogram compared with U.S.-born women, according to the Oc